Provided by Tiger Trade Technology Pte. Ltd.

MDA Space Ltd.

28.02
-0.3500-1.23%
Post-market: 27.90-0.1249-0.45%17:36 EDT
Volume:1.31M
Turnover:36.74M
Market Cap:4.54B
PE:50.20
High:28.66
Open:28.50
Low:27.57
Close:28.37
52wk High:49.37
52wk Low:15.00
Shares:162.00M
Float Shares:160.00M
Volume Ratio:1.24
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5582
EPS(LYR):0.6126
ROE:6.68%
ROA:2.75%
PB:3.32
PE(LYR):45.74

Loading ...

Two Killed in Israel After Rocket Fire, Emergency Service Says -- WSJ

Dow Jones
·
Mar 18

Canadian Defense Tech Firms Ride Global Military Spending Boom -- Market Talk

Dow Jones
·
Mar 18

Canada’s High-Flying MDA Space (MDA) Holds U.S. IPO

TIPRANKS
·
Mar 13

MDA Space in ‘very strong position:’ CEO after US$300M IPO on NYSE

Bloomberg
·
Mar 13

MDA Space Shares Lose Steam After Climbing on New York Debut

Dow Jones
·
Mar 13

Stock Track | MDA Space Plummets 5.36% in Pre-market as U.S. IPO Priced Below Current Market Value

Stock Track
·
Mar 12

NYSE Content Update: Canada-Based MDA Space Shoots for the Stars in its NYSE Debut

prnewswire
·
Mar 12

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

GlobeNewswire
·
Mar 12

Toronto's MDA Space Eyes NYSE Listing as Defense Boom Fuels Demand

Dow Jones
·
Mar 12

MDA Space Looks to Tap Into U.S. Market with NYSE IPO -- Market Talk

Dow Jones
·
Mar 11

Canadian Satellite Provider MDA Space Files for US IPO Targeting $300 Million

Stock News
·
Mar 11

Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference

GlobeNewswire
·
Mar 10

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy

GlobeNewswire
·
Mar 09

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

GlobeNewswire
·
Mar 09

MDA Space Earnings Call Highlights Record Growth, Trade-Offs

TIPRANKS
·
Mar 09

MDA Space Ltd Price Target Raised to C$50.00/Share From C$45.00 by BMO Capital Markets

Dow Jones
·
Mar 06

MDA Space price target raised to C$49 from C$42 at Scotiabank

TIPRANKS
·
Mar 06

Stifel Nicolaus Reaffirms Their Buy Rating on MDA Space Ltd (MDA)

TIPRANKS
·
Mar 05

ATB Cormark Capital Markets Sticks to Its Buy Rating for MDA Space Ltd (MDA)

TIPRANKS
·
Mar 05

Press Release: PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

Dow Jones
·
Mar 05